Literature DB >> 2003804

Synthesis of platelet activating factor by ocular tissue from inflamed eyes.

J T Rosenbaum1, R S Boney, J R Samples, F H Valone.   

Abstract

Platelet activating factors (PAFs) are a family of ether lipids with properties that suggest a major role in inflammation. We have previously implicated PAFs in ocular inflammation based on the inhibition of several rabbit models of iritis with a specific PAF receptor antagonist. We have tested ocular tissues for the ability to synthesize PAF. Iris, ciliary body, cornea, and/or retina were carefully dissected from New Zealand white rabbits, and tissue from four eyes was pooled. Tissues were stimulated with calcium ionophore (10 mumol/L), and supernatants were extracted with chloroform-methanol. Platelet-aggregating activity was found in the chloroform phase in 2 of 9, 1 of 8, 0 of 9, and 3 of 9 studies involving iris, retina, ciliary body, or cornea, respectively. Twenty-four hours after the intravitreal injection of 125 ng of endotoxin, aggregating activity was consistently detectable from supernatants of stimulated iris and ciliary body, occasionally present from stimulated retina but not detectable from cornea. The shape of the aggregation curve resembled that produced by 0.5 to 2.0 ng of authentic PAF. Moreover, the aggregation could be completely inhibited by a PAF receptor antagonist and the aggregating activity chromatographed identically on high-performance liquid chromatography to a PAF standard. These studies indicate that PAF-like activity could be detected from several ocular tissues subsequent to inflammation. Iris, ciliary body, retina, vascular endothelium, and/or leukocytes could each contribute to the presence of this inflammatory mediator.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003804     DOI: 10.1001/archopht.1991.01080030112049

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.

Authors:  Long Cheng; Xiao Han; Yuguang Shi
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-09-22       Impact factor: 4.310

2.  Light and lithium effects in the rat retina: modification by the PAF antagonist BN 52021.

Authors:  C Remé; Q Wei; K Munz; H Jung; M Doly; M T Droy-Lefaix
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study.

Authors:  Marilita M Moschos; Eirini Nitoda; Irini P Chatziralli; Georgios D Panos; Constantinos A Demopoulos
Journal:  Drug Des Devel Ther       Date:  2016-12-07       Impact factor: 4.162

4.  Permeability of blood-tear barrier to fluorescein and albumin after application of platelet-activating factor to the eye of the guinea pig.

Authors:  J L van Delft; F Meijer; J A van Best; N J van Haeringen
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.